Everett Magann
Concepts (773)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amniotic Fluid | 69 | 2023 | 113 | 12.920 |
Why?
| Pregnancy | 338 | 2023 | 2620 | 12.830 |
Why?
| Pregnancy Complications | 53 | 2023 | 384 | 10.760 |
Why?
| Ultrasonography, Prenatal | 66 | 2023 | 177 | 10.470 |
Why?
| Pregnancy Outcome | 90 | 2023 | 249 | 10.080 |
Why?
| Oligohydramnios | 44 | 2023 | 60 | 6.690 |
Why?
| Cesarean Section | 63 | 2023 | 179 | 6.040 |
Why?
| Obstetrics | 22 | 2022 | 89 | 5.830 |
Why?
| Premature Birth | 27 | 2023 | 154 | 5.520 |
Why?
| Delivery, Obstetric | 42 | 2020 | 118 | 5.130 |
Why?
| Female | 360 | 2023 | 28441 | 5.000 |
Why?
| Gestational Age | 76 | 2023 | 435 | 4.660 |
Why?
| Prenatal Care | 14 | 2023 | 116 | 3.870 |
Why?
| Polyhydramnios | 20 | 2023 | 33 | 3.740 |
Why?
| Telemedicine | 13 | 2023 | 449 | 3.630 |
Why?
| Humans | 367 | 2023 | 54284 | 3.520 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 33 | 3.470 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.410 |
Why?
| Infant, Newborn | 109 | 2023 | 2907 | 3.340 |
Why?
| Adult | 210 | 2022 | 14207 | 3.340 |
Why?
| Placenta | 12 | 2022 | 135 | 3.280 |
Why?
| Obstetric Labor Complications | 19 | 2020 | 31 | 3.220 |
Why?
| Fetal Membranes, Premature Rupture | 7 | 2023 | 23 | 2.930 |
Why?
| Uterine Rupture | 5 | 2023 | 13 | 2.790 |
Why?
| Pregnancy, High-Risk | 16 | 2021 | 65 | 2.740 |
Why?
| Fetal Diseases | 8 | 2022 | 54 | 2.700 |
Why?
| Military Personnel | 15 | 2013 | 174 | 2.580 |
Why?
| Pre-Eclampsia | 22 | 2020 | 56 | 2.520 |
Why?
| Hypertension, Pregnancy-Induced | 3 | 2022 | 17 | 2.400 |
Why?
| Twins | 18 | 2014 | 32 | 2.270 |
Why?
| HELLP Syndrome | 25 | 2007 | 25 | 2.260 |
Why?
| Birth Weight | 29 | 2020 | 126 | 2.140 |
Why?
| Labor, Induced | 17 | 2020 | 22 | 2.050 |
Why?
| Prospective Studies | 74 | 2023 | 2604 | 2.020 |
Why?
| Risk Factors | 56 | 2023 | 3935 | 1.880 |
Why?
| Parturition | 8 | 2023 | 54 | 1.770 |
Why?
| Fetal Growth Retardation | 15 | 2016 | 45 | 1.740 |
Why?
| Diabetes, Gestational | 5 | 2021 | 54 | 1.700 |
Why?
| Gynecology | 8 | 2022 | 50 | 1.680 |
Why?
| Labor, Obstetric | 13 | 2023 | 41 | 1.670 |
Why?
| Obstetric Labor, Premature | 18 | 2016 | 42 | 1.650 |
Why?
| Infant, Small for Gestational Age | 12 | 2022 | 34 | 1.590 |
Why?
| Retrospective Studies | 67 | 2023 | 6432 | 1.480 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 8 | 1.450 |
Why?
| Surgical Wound Dehiscence | 4 | 2021 | 21 | 1.450 |
Why?
| Pregnancy Complications, Cardiovascular | 8 | 2022 | 35 | 1.440 |
Why?
| Uterine Diseases | 3 | 2020 | 8 | 1.390 |
Why?
| Vaginal Birth after Cesarean | 5 | 2023 | 9 | 1.360 |
Why?
| Congenital Abnormalities | 7 | 2021 | 112 | 1.350 |
Why?
| Rural Health Services | 4 | 2016 | 175 | 1.340 |
Why?
| Domestic Violence | 4 | 2012 | 24 | 1.280 |
Why?
| Peripartum Period | 4 | 2022 | 17 | 1.260 |
Why?
| Young Adult | 39 | 2021 | 4318 | 1.260 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 75 | 1.250 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 22 | 1.230 |
Why?
| Fetal Distress | 20 | 2020 | 21 | 1.230 |
Why?
| Ultrasonography, Doppler, Color | 5 | 2019 | 35 | 1.230 |
Why?
| Obesity, Morbid | 3 | 2018 | 88 | 1.210 |
Why?
| Fetal Death | 6 | 2022 | 22 | 1.210 |
Why?
| Pregnancy Trimester, Third | 17 | 2022 | 66 | 1.180 |
Why?
| Fetal Weight | 7 | 2014 | 11 | 1.170 |
Why?
| Fetus | 7 | 2020 | 227 | 1.170 |
Why?
| Dye Dilution Technique | 8 | 2014 | 17 | 1.160 |
Why?
| Postpartum Period | 13 | 2022 | 118 | 1.150 |
Why?
| Ultrasonography | 19 | 2021 | 480 | 1.130 |
Why?
| Uterus | 10 | 2023 | 98 | 1.130 |
Why?
| Pregnancy Complications, Hematologic | 6 | 2021 | 14 | 1.120 |
Why?
| Cervical Ripening | 7 | 2016 | 8 | 1.120 |
Why?
| Parity | 20 | 2020 | 51 | 1.100 |
Why?
| Dystocia | 9 | 2014 | 10 | 1.060 |
Why?
| Fetal Macrosomia | 12 | 2015 | 21 | 1.050 |
Why?
| Maternal Mortality | 6 | 2020 | 25 | 1.050 |
Why?
| Hypertension | 12 | 2021 | 564 | 1.040 |
Why?
| Body Mass Index | 13 | 2020 | 713 | 1.020 |
Why?
| Referral and Consultation | 5 | 2015 | 307 | 1.010 |
Why?
| Adolescent | 54 | 2022 | 6897 | 1.000 |
Why?
| Morbidity | 7 | 2022 | 149 | 0.970 |
Why?
| Hemorrhage | 5 | 2022 | 208 | 0.970 |
Why?
| Uterine Prolapse | 1 | 2023 | 4 | 0.950 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 3 | 0.930 |
Why?
| Cervix Uteri | 8 | 2014 | 53 | 0.920 |
Why?
| Mass Screening | 5 | 2012 | 370 | 0.920 |
Why?
| Health Services Accessibility | 4 | 2021 | 432 | 0.900 |
Why?
| Time Factors | 33 | 2018 | 3213 | 0.900 |
Why?
| Adrenal Cortex Hormones | 4 | 2017 | 95 | 0.880 |
Why?
| Adenomyosis | 1 | 2022 | 2 | 0.880 |
Why?
| Pregnancy, Multiple | 5 | 2007 | 21 | 0.870 |
Why?
| Prenatal Diagnosis | 7 | 2022 | 108 | 0.860 |
Why?
| Maternal Death | 1 | 2022 | 8 | 0.860 |
Why?
| Blood Loss, Surgical | 7 | 2012 | 79 | 0.850 |
Why?
| Cystitis | 1 | 2022 | 18 | 0.840 |
Why?
| Rural Population | 4 | 2022 | 600 | 0.840 |
Why?
| Respiratory Distress Syndrome, Newborn | 8 | 2017 | 53 | 0.830 |
Why?
| Health Status Disparities | 2 | 2022 | 219 | 0.820 |
Why?
| Arkansas | 14 | 2022 | 2100 | 0.810 |
Why?
| Pregnancy Complications, Neoplastic | 2 | 2019 | 21 | 0.810 |
Why?
| Hyperparathyroidism | 1 | 2022 | 50 | 0.810 |
Why?
| Privacy | 1 | 2021 | 18 | 0.800 |
Why?
| Surgical Wound Infection | 5 | 2017 | 126 | 0.800 |
Why?
| Obesity | 8 | 2020 | 1202 | 0.790 |
Why?
| Postmenopause | 1 | 2022 | 102 | 0.790 |
Why?
| Communication Barriers | 1 | 2021 | 38 | 0.780 |
Why?
| Education, Medical | 1 | 2022 | 107 | 0.760 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 61 | 0.750 |
Why?
| Torsion Abnormality | 1 | 2020 | 6 | 0.750 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 492 | 0.740 |
Why?
| Pregnancy, Twin | 3 | 2014 | 7 | 0.740 |
Why?
| Medically Underserved Area | 1 | 2020 | 46 | 0.730 |
Why?
| Umbilical Cord | 1 | 2020 | 33 | 0.730 |
Why?
| Predictive Value of Tests | 29 | 2019 | 1048 | 0.720 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.720 |
Why?
| Placenta Diseases | 1 | 2019 | 12 | 0.720 |
Why?
| Fetal Monitoring | 10 | 2013 | 45 | 0.700 |
Why?
| Health Personnel | 2 | 2020 | 246 | 0.700 |
Why?
| Disease Management | 1 | 2021 | 184 | 0.690 |
Why?
| Simplexvirus | 1 | 2019 | 12 | 0.690 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.690 |
Why?
| Women's Health Services | 1 | 2019 | 16 | 0.690 |
Why?
| Military Medicine | 1 | 2019 | 21 | 0.680 |
Why?
| Herpes Simplex | 1 | 2019 | 24 | 0.680 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.670 |
Why?
| Heart Rate, Fetal | 14 | 2016 | 73 | 0.670 |
Why?
| Dexamethasone | 8 | 2016 | 435 | 0.670 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 256 | 0.670 |
Why?
| Uterine Inversion | 1 | 2018 | 2 | 0.660 |
Why?
| Pregnancy Trimester, Second | 12 | 2020 | 28 | 0.660 |
Why?
| Stillbirth | 4 | 2022 | 31 | 0.660 |
Why?
| Fetal Blood | 11 | 2010 | 67 | 0.660 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 117 | 0.650 |
Why?
| Mississippi | 12 | 2015 | 103 | 0.650 |
Why?
| Women, Working | 2 | 2012 | 7 | 0.640 |
Why?
| Sensitivity and Specificity | 22 | 2017 | 923 | 0.630 |
Why?
| Diverticulum | 1 | 2017 | 22 | 0.620 |
Why?
| Patient Satisfaction | 3 | 2023 | 304 | 0.620 |
Why?
| Apgar Score | 20 | 2018 | 35 | 0.590 |
Why?
| Internship and Residency | 2 | 2022 | 501 | 0.590 |
Why?
| Infant, Premature | 5 | 2015 | 335 | 0.590 |
Why?
| Uterine Retroversion | 1 | 2016 | 3 | 0.590 |
Why?
| Magnesium Sulfate | 7 | 2016 | 13 | 0.590 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 171 | 0.580 |
Why?
| Infant Mortality | 10 | 2013 | 70 | 0.580 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 10 | 0.570 |
Why?
| Stroke | 1 | 2022 | 526 | 0.570 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.570 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.570 |
Why?
| Foodborne Diseases | 1 | 2016 | 10 | 0.570 |
Why?
| Gastroschisis | 1 | 2016 | 40 | 0.560 |
Why?
| Genetic Counseling | 1 | 2016 | 43 | 0.560 |
Why?
| Reproducibility of Results | 14 | 2021 | 1304 | 0.550 |
Why?
| Respiration Disorders | 1 | 2015 | 25 | 0.540 |
Why?
| Hydroxyprogesterones | 4 | 2021 | 8 | 0.540 |
Why?
| Blood Pressure | 9 | 2022 | 587 | 0.540 |
Why?
| Death Certificates | 1 | 2015 | 17 | 0.540 |
Why?
| Genetic Testing | 1 | 2016 | 135 | 0.530 |
Why?
| Birth Certificates | 1 | 2015 | 20 | 0.530 |
Why?
| Adenocarcinoma | 1 | 2019 | 428 | 0.530 |
Why?
| Tertiary Care Centers | 2 | 2015 | 83 | 0.530 |
Why?
| Tocolysis | 5 | 2015 | 5 | 0.530 |
Why?
| Uterine Hemorrhage | 4 | 2021 | 11 | 0.520 |
Why?
| Odds Ratio | 9 | 2016 | 604 | 0.520 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 11 | 0.520 |
Why?
| Tocolytic Agents | 6 | 2015 | 7 | 0.510 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 596 | 0.510 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 15 | 0.510 |
Why?
| Exercise | 3 | 2009 | 552 | 0.500 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1604 | 0.500 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 32 | 0.500 |
Why?
| Spouse Abuse | 3 | 2012 | 18 | 0.500 |
Why?
| Fractures, Bone | 3 | 2014 | 119 | 0.500 |
Why?
| Automobile Driving | 1 | 2014 | 30 | 0.500 |
Why?
| Pregnancy, Prolonged | 5 | 2008 | 6 | 0.480 |
Why?
| Lung Neoplasms | 2 | 2019 | 642 | 0.480 |
Why?
| Regression Analysis | 12 | 2018 | 445 | 0.470 |
Why?
| Multivariate Analysis | 8 | 2015 | 643 | 0.470 |
Why?
| Catheterization | 2 | 2011 | 108 | 0.460 |
Why?
| Truth Disclosure | 1 | 2013 | 18 | 0.460 |
Why?
| Endometritis | 6 | 2010 | 8 | 0.460 |
Why?
| Posture | 2 | 2005 | 80 | 0.450 |
Why?
| Guideline Adherence | 3 | 2013 | 148 | 0.450 |
Why?
| Algorithms | 4 | 2013 | 697 | 0.450 |
Why?
| Eclampsia | 7 | 2003 | 8 | 0.440 |
Why?
| Case-Control Studies | 14 | 2023 | 1228 | 0.440 |
Why?
| Prevalence | 9 | 2012 | 1025 | 0.440 |
Why?
| Ideal Body Weight | 1 | 2012 | 7 | 0.430 |
Why?
| Rupture, Spontaneous | 3 | 2022 | 26 | 0.430 |
Why?
| Brain Injuries | 1 | 2014 | 183 | 0.430 |
Why?
| Body Weights and Measures | 1 | 2012 | 20 | 0.430 |
Why?
| Pilot Projects | 5 | 2022 | 808 | 0.430 |
Why?
| United States | 19 | 2021 | 5217 | 0.430 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 119 | 0.430 |
Why?
| Blood Transfusion | 5 | 2021 | 138 | 0.410 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.410 |
Why?
| Acidosis | 7 | 2004 | 38 | 0.410 |
Why?
| Incidence | 15 | 2020 | 1082 | 0.410 |
Why?
| Contraception | 1 | 2011 | 29 | 0.410 |
Why?
| Triage | 4 | 2020 | 76 | 0.400 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.400 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.400 |
Why?
| Diagnosis, Differential | 7 | 2019 | 1136 | 0.400 |
Why?
| Oxytocin | 2 | 2005 | 18 | 0.400 |
Why?
| Cohort Studies | 14 | 2021 | 1543 | 0.390 |
Why?
| Middle Aged | 15 | 2022 | 13088 | 0.390 |
Why?
| Dinoprostone | 4 | 1999 | 55 | 0.390 |
Why?
| Puerperal Disorders | 7 | 2015 | 25 | 0.380 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.380 |
Why?
| Clinical Competence | 4 | 2022 | 446 | 0.380 |
Why?
| Fluid Therapy | 2 | 2018 | 87 | 0.380 |
Why?
| Terbutaline | 3 | 2008 | 6 | 0.380 |
Why?
| Umbilical Arteries | 11 | 2006 | 22 | 0.370 |
Why?
| Treatment Outcome | 14 | 2022 | 5604 | 0.370 |
Why?
| Amniocentesis | 10 | 2004 | 15 | 0.360 |
Why?
| Quality of Life | 3 | 2023 | 922 | 0.360 |
Why?
| Battered Women | 1 | 2009 | 4 | 0.350 |
Why?
| Lung | 6 | 2011 | 507 | 0.350 |
Why?
| Amnion | 5 | 2020 | 11 | 0.350 |
Why?
| Reference Values | 9 | 2019 | 354 | 0.350 |
Why?
| Pregnant Women | 3 | 2022 | 80 | 0.340 |
Why?
| Birth Injuries | 5 | 2013 | 9 | 0.340 |
Why?
| Chi-Square Distribution | 9 | 2012 | 318 | 0.340 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 94 | 0.340 |
Why?
| Coloring Agents | 4 | 2004 | 84 | 0.330 |
Why?
| Bibliometrics | 1 | 2008 | 24 | 0.330 |
Why?
| Fibronectins | 3 | 2011 | 41 | 0.330 |
Why?
| Progestins | 3 | 2014 | 14 | 0.320 |
Why?
| Publishing | 1 | 2008 | 45 | 0.320 |
Why?
| Infant, Newborn, Diseases | 3 | 2014 | 64 | 0.320 |
Why?
| Chorioamnionitis | 4 | 2017 | 21 | 0.310 |
Why?
| Homocysteine | 1 | 2008 | 126 | 0.310 |
Why?
| ROC Curve | 15 | 2016 | 259 | 0.310 |
Why?
| Oxytocics | 3 | 2016 | 6 | 0.300 |
Why?
| Hospitalization | 4 | 2017 | 705 | 0.300 |
Why?
| Hospitals | 2 | 2020 | 188 | 0.290 |
Why?
| Hypercalcemia | 1 | 2006 | 36 | 0.280 |
Why?
| Puerperal Infection | 4 | 2005 | 6 | 0.280 |
Why?
| Brachial Plexus | 5 | 2013 | 12 | 0.280 |
Why?
| Risk Assessment | 9 | 2019 | 1361 | 0.280 |
Why?
| Remote Consultation | 2 | 2017 | 29 | 0.280 |
Why?
| Prognosis | 8 | 2018 | 2118 | 0.280 |
Why?
| Maternal Age | 6 | 2015 | 46 | 0.280 |
Why?
| Nifedipine | 3 | 2015 | 24 | 0.280 |
Why?
| Logistic Models | 7 | 2011 | 995 | 0.280 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.280 |
Why?
| Platelet Count | 10 | 2001 | 77 | 0.270 |
Why?
| Renal Insufficiency | 2 | 2006 | 138 | 0.270 |
Why?
| Hydrogen-Ion Concentration | 13 | 2011 | 194 | 0.270 |
Why?
| Lifting | 1 | 2005 | 2 | 0.270 |
Why?
| Medicaid | 4 | 2021 | 267 | 0.270 |
Why?
| Body Weight | 3 | 2013 | 578 | 0.270 |
Why?
| Cerebral Palsy | 3 | 2016 | 43 | 0.270 |
Why?
| Placenta, Retained | 3 | 2016 | 4 | 0.270 |
Why?
| Noise | 1 | 2005 | 38 | 0.270 |
Why?
| Extraembryonic Membranes | 3 | 2001 | 4 | 0.260 |
Why?
| Exercise Therapy | 2 | 2023 | 123 | 0.260 |
Why?
| Smoking | 4 | 2018 | 556 | 0.250 |
Why?
| Chorion | 1 | 2004 | 1 | 0.250 |
Why?
| Male | 17 | 2022 | 27334 | 0.250 |
Why?
| Intensive Care, Neonatal | 2 | 2003 | 24 | 0.240 |
Why?
| Patient Care Team | 3 | 2021 | 273 | 0.240 |
Why?
| Depression | 3 | 2017 | 595 | 0.240 |
Why?
| Labor Stage, First | 5 | 2015 | 8 | 0.230 |
Why?
| Home Infusion Therapy | 1 | 2003 | 1 | 0.230 |
Why?
| Weight Gain | 4 | 2013 | 243 | 0.230 |
Why?
| Urinary Tract Infections | 1 | 2023 | 52 | 0.230 |
Why?
| Blood Volume | 2 | 2018 | 69 | 0.230 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.230 |
Why?
| Confidence Intervals | 5 | 2016 | 167 | 0.230 |
Why?
| International Classification of Diseases | 2 | 2015 | 65 | 0.220 |
Why?
| Marital Status | 2 | 2009 | 20 | 0.220 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2010 | 552 | 0.220 |
Why?
| Pubic Symphysis | 2 | 2015 | 3 | 0.220 |
Why?
| Hospitals, Military | 2 | 2014 | 7 | 0.220 |
Why?
| Energy Metabolism | 2 | 2013 | 311 | 0.220 |
Why?
| Intrauterine Devices | 2 | 2012 | 5 | 0.220 |
Why?
| Mandatory Reporting | 2 | 2012 | 13 | 0.210 |
Why?
| Embryo Implantation | 1 | 2002 | 7 | 0.210 |
Why?
| Hospitals, Teaching | 2 | 2020 | 58 | 0.210 |
Why?
| Acute Disease | 2 | 2022 | 403 | 0.210 |
Why?
| Mothers | 2 | 2017 | 247 | 0.200 |
Why?
| Licensure | 1 | 2021 | 16 | 0.200 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 13 | 0.200 |
Why?
| Anti-Inflammatory Agents | 2 | 2000 | 175 | 0.200 |
Why?
| Term Birth | 3 | 2015 | 21 | 0.200 |
Why?
| South Carolina | 3 | 2015 | 42 | 0.200 |
Why?
| Technology | 1 | 2021 | 18 | 0.200 |
Why?
| Reproductive Health | 1 | 2021 | 10 | 0.200 |
Why?
| Uterine Contraction | 3 | 2008 | 41 | 0.200 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 124 | 0.200 |
Why?
| Risk Adjustment | 1 | 2021 | 27 | 0.200 |
Why?
| Hysterectomy | 4 | 2021 | 88 | 0.190 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.190 |
Why?
| Fatal Outcome | 2 | 2019 | 225 | 0.190 |
Why?
| Prolapse | 1 | 2020 | 7 | 0.190 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.190 |
Why?
| Maternal Health Services | 1 | 2021 | 31 | 0.190 |
Why?
| Infant | 6 | 2023 | 3817 | 0.190 |
Why?
| Sleep | 1 | 2002 | 188 | 0.190 |
Why?
| Biophysical Phenomena | 3 | 2014 | 20 | 0.190 |
Why?
| Probability | 6 | 2008 | 176 | 0.190 |
Why?
| Patient Care Planning | 1 | 2020 | 79 | 0.180 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.180 |
Why?
| Postoperative Complications | 7 | 2017 | 1033 | 0.180 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 2 | 0.180 |
Why?
| L-Lactate Dehydrogenase | 7 | 2001 | 79 | 0.180 |
Why?
| Cerclage, Cervical | 2 | 2011 | 7 | 0.180 |
Why?
| Chest Pain | 1 | 2019 | 65 | 0.180 |
Why?
| Dyspnea | 1 | 2019 | 78 | 0.180 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1693 | 0.180 |
Why?
| Abdominal Pain | 1 | 2020 | 77 | 0.180 |
Why?
| Quality Improvement | 1 | 2022 | 245 | 0.180 |
Why?
| Honduras | 1 | 2019 | 2 | 0.170 |
Why?
| Guatemala | 1 | 2019 | 4 | 0.170 |
Why?
| Colombia | 1 | 2019 | 13 | 0.170 |
Why?
| Acyclovir | 1 | 2019 | 10 | 0.170 |
Why?
| Contraception Behavior | 1 | 2019 | 12 | 0.170 |
Why?
| Anticonvulsants | 2 | 2016 | 129 | 0.170 |
Why?
| Office Visits | 2 | 2013 | 49 | 0.170 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 8 | 0.170 |
Why?
| Infant, Premature, Diseases | 3 | 2020 | 91 | 0.170 |
Why?
| Australia | 3 | 2012 | 85 | 0.170 |
Why?
| Mental Health Services | 1 | 2022 | 242 | 0.170 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1213 | 0.170 |
Why?
| Medical Records | 4 | 2014 | 92 | 0.170 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 3 | 0.170 |
Why?
| Internet | 1 | 2021 | 275 | 0.170 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 87 | 0.170 |
Why?
| Critical Illness | 1 | 2021 | 344 | 0.160 |
Why?
| Child | 2 | 2023 | 7341 | 0.160 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 14 | 0.160 |
Why?
| Linear Models | 7 | 2021 | 309 | 0.160 |
Why?
| Wounds and Injuries | 3 | 2009 | 321 | 0.160 |
Why?
| Fetal Development | 2 | 2016 | 64 | 0.160 |
Why?
| Early Diagnosis | 1 | 2018 | 96 | 0.160 |
Why?
| Seasons | 1 | 1998 | 98 | 0.160 |
Why?
| Temperature | 2 | 1998 | 177 | 0.160 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 67 | 0.160 |
Why?
| Age Factors | 3 | 2011 | 1198 | 0.150 |
Why?
| Medical Laboratory Personnel | 1 | 1997 | 5 | 0.150 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 608 | 0.150 |
Why?
| Actinomyces | 1 | 2017 | 9 | 0.150 |
Why?
| Antiviral Agents | 1 | 2019 | 188 | 0.150 |
Why?
| Proportional Hazards Models | 2 | 2015 | 431 | 0.150 |
Why?
| Emergency Service, Hospital | 1 | 2022 | 539 | 0.150 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.150 |
Why?
| Emergency Medical Services | 2 | 2012 | 126 | 0.150 |
Why?
| Aged | 3 | 2022 | 10054 | 0.150 |
Why?
| Indomethacin | 2 | 2015 | 40 | 0.150 |
Why?
| Severity of Illness Index | 7 | 2010 | 1084 | 0.150 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 29 | 0.150 |
Why?
| Professional Competence | 1 | 1997 | 47 | 0.150 |
Why?
| Malpractice | 2 | 2008 | 16 | 0.150 |
Why?
| Fetal Organ Maturity | 5 | 2000 | 10 | 0.150 |
Why?
| Telephone | 2 | 2017 | 75 | 0.150 |
Why?
| Hematocrit | 3 | 2012 | 51 | 0.140 |
Why?
| Systole | 1 | 2016 | 80 | 0.140 |
Why?
| Brain Waves | 1 | 2016 | 23 | 0.140 |
Why?
| Patient Care Management | 1 | 2016 | 21 | 0.140 |
Why?
| Symptom Assessment | 1 | 2016 | 38 | 0.140 |
Why?
| Hospitals, University | 3 | 2014 | 89 | 0.140 |
Why?
| Antioxidants | 1 | 2019 | 297 | 0.140 |
Why?
| Suicidal Ideation | 1 | 2017 | 96 | 0.140 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 5 | 0.140 |
Why?
| Trial of Labor | 5 | 2008 | 5 | 0.140 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 491 | 0.140 |
Why?
| Colposcopy | 1 | 2016 | 19 | 0.140 |
Why?
| Socioeconomic Factors | 2 | 2016 | 642 | 0.140 |
Why?
| Kidney | 1 | 2021 | 820 | 0.140 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.140 |
Why?
| Clavicle | 2 | 2013 | 5 | 0.140 |
Why?
| Hospitals, Community | 2 | 2014 | 21 | 0.140 |
Why?
| Humeral Fractures | 2 | 2013 | 10 | 0.140 |
Why?
| Twins, Dizygotic | 1 | 1995 | 6 | 0.140 |
Why?
| Urologic Diseases | 1 | 2015 | 11 | 0.130 |
Why?
| Employment | 1 | 1996 | 95 | 0.130 |
Why?
| Magnetoencephalography | 1 | 2016 | 129 | 0.130 |
Why?
| Neuroprotective Agents | 1 | 2016 | 125 | 0.130 |
Why?
| Language Development Disorders | 1 | 2015 | 18 | 0.130 |
Why?
| Pregnancy in Diabetics | 4 | 2010 | 25 | 0.130 |
Why?
| Humidity | 1 | 1995 | 7 | 0.130 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.130 |
Why?
| Insulin | 2 | 2007 | 510 | 0.130 |
Why?
| Animal Assisted Therapy | 1 | 2014 | 3 | 0.130 |
Why?
| Episiotomy | 1 | 2014 | 8 | 0.130 |
Why?
| Follow-Up Studies | 7 | 2017 | 2387 | 0.130 |
Why?
| Sheep | 1 | 2014 | 88 | 0.120 |
Why?
| Southwestern United States | 1 | 2014 | 21 | 0.120 |
Why?
| Progesterone | 1 | 2014 | 69 | 0.120 |
Why?
| Naval Medicine | 2 | 2009 | 5 | 0.120 |
Why?
| Louisiana | 1 | 2014 | 58 | 0.120 |
Why?
| Safety | 1 | 2015 | 92 | 0.120 |
Why?
| Southeastern United States | 1 | 2014 | 56 | 0.120 |
Why?
| Misoprostol | 2 | 2016 | 4 | 0.120 |
Why?
| Physician-Patient Relations | 2 | 2013 | 150 | 0.120 |
Why?
| Stress, Psychological | 3 | 2008 | 270 | 0.120 |
Why?
| Calcium Channel Blockers | 1 | 1994 | 72 | 0.120 |
Why?
| Clinical Protocols | 2 | 2012 | 122 | 0.120 |
Why?
| Academic Medical Centers | 1 | 2014 | 141 | 0.120 |
Why?
| Estradiol | 1 | 1995 | 219 | 0.120 |
Why?
| Health Care Costs | 1 | 2015 | 171 | 0.120 |
Why?
| Xylenes | 1 | 1993 | 3 | 0.120 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 19 | 0.120 |
Why?
| Premedication | 1 | 1993 | 18 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 291 | 0.120 |
Why?
| Cefazolin | 1 | 1993 | 11 | 0.120 |
Why?
| Healthy People Programs | 1 | 2013 | 4 | 0.120 |
Why?
| Curettage | 1 | 1993 | 15 | 0.120 |
Why?
| Brain Diseases | 2 | 2005 | 87 | 0.110 |
Why?
| Analysis of Variance | 7 | 2001 | 635 | 0.110 |
Why?
| Depression, Postpartum | 1 | 2013 | 42 | 0.110 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 276 | 0.110 |
Why?
| Anti-Infective Agents, Local | 1 | 1993 | 24 | 0.110 |
Why?
| Counseling | 1 | 2014 | 149 | 0.110 |
Why?
| Placenta Previa | 1 | 1993 | 6 | 0.110 |
Why?
| Intraoperative Care | 1 | 1993 | 57 | 0.110 |
Why?
| Oxidative Stress | 1 | 2019 | 958 | 0.110 |
Why?
| Image Enhancement | 1 | 2013 | 56 | 0.110 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.110 |
Why?
| Data Collection | 2 | 2012 | 321 | 0.110 |
Why?
| Peritoneum | 1 | 2012 | 12 | 0.110 |
Why?
| Abdominal Wall | 1 | 2012 | 10 | 0.110 |
Why?
| Digestive System | 1 | 2012 | 19 | 0.110 |
Why?
| Retroperitoneal Space | 1 | 2012 | 24 | 0.110 |
Why?
| Patient Admission | 2 | 2005 | 78 | 0.110 |
Why?
| Government Agencies | 1 | 2012 | 14 | 0.110 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 231 | 0.110 |
Why?
| Abdomen | 4 | 2006 | 83 | 0.110 |
Why?
| Birth Rate | 1 | 2012 | 4 | 0.110 |
Why?
| Local Government | 1 | 2012 | 25 | 0.110 |
Why?
| Hemoglobins | 1 | 2013 | 126 | 0.110 |
Why?
| Return to Work | 1 | 2012 | 12 | 0.110 |
Why?
| Anxiety | 1 | 2014 | 279 | 0.110 |
Why?
| Reference Standards | 1 | 2012 | 63 | 0.110 |
Why?
| Patient Care | 1 | 2012 | 61 | 0.110 |
Why?
| Administration, Intravaginal | 4 | 2014 | 8 | 0.100 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.100 |
Why?
| Urination | 1 | 2011 | 18 | 0.100 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.100 |
Why?
| Family Practice | 1 | 2012 | 64 | 0.100 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.100 |
Why?
| Drug Eruptions | 1 | 2011 | 14 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 247 | 0.100 |
Why?
| Emotions | 1 | 2013 | 168 | 0.100 |
Why?
| Breech Presentation | 2 | 2005 | 2 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 397 | 0.100 |
Why?
| Traction | 1 | 2011 | 6 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 83 | 0.100 |
Why?
| Personal Satisfaction | 1 | 2012 | 90 | 0.100 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.100 |
Why?
| Deglutition | 1 | 2011 | 37 | 0.100 |
Why?
| Surgical Sponges | 1 | 2011 | 7 | 0.100 |
Why?
| Qualitative Research | 1 | 2013 | 331 | 0.100 |
Why?
| Guidelines as Topic | 1 | 2012 | 125 | 0.100 |
Why?
| Fetal Proteins | 1 | 2011 | 4 | 0.100 |
Why?
| Cesarean Section, Repeat | 2 | 2003 | 6 | 0.100 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2010 | 69 | 0.100 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.100 |
Why?
| Medical Errors | 1 | 2011 | 34 | 0.100 |
Why?
| Periodicals as Topic | 2 | 2010 | 65 | 0.100 |
Why?
| Metronidazole | 1 | 2011 | 30 | 0.100 |
Why?
| Genomic Imprinting | 2 | 2007 | 11 | 0.100 |
Why?
| Infusions, Intravenous | 2 | 2003 | 231 | 0.100 |
Why?
| Weight-Bearing | 1 | 2011 | 56 | 0.100 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 7 | 0.100 |
Why?
| Communication | 1 | 2013 | 273 | 0.100 |
Why?
| Hemostasis, Surgical | 2 | 2005 | 12 | 0.100 |
Why?
| RNA, Untranslated | 1 | 2010 | 17 | 0.100 |
Why?
| Hypersensitivity | 1 | 2011 | 82 | 0.100 |
Why?
| Hemodynamics | 1 | 2012 | 290 | 0.090 |
Why?
| Aviation | 1 | 2010 | 7 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 64 | 0.090 |
Why?
| Appendicitis | 2 | 2009 | 77 | 0.090 |
Why?
| Length of Stay | 3 | 2021 | 683 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2011 | 746 | 0.090 |
Why?
| Betamethasone | 2 | 2016 | 5 | 0.090 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 3 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 543 | 0.090 |
Why?
| Haplotypes | 2 | 2007 | 105 | 0.090 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 136 | 0.090 |
Why?
| Fetal Movement | 2 | 2000 | 23 | 0.090 |
Why?
| Pelvis | 2 | 2015 | 76 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 110 | 0.090 |
Why?
| Physical Examination | 3 | 2003 | 99 | 0.090 |
Why?
| Anti-Bacterial Agents | 3 | 2023 | 820 | 0.090 |
Why?
| Heart Diseases | 2 | 2005 | 237 | 0.090 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 4 | 0.090 |
Why?
| Perinatal Care | 2 | 2020 | 26 | 0.090 |
Why?
| Child, Preschool | 2 | 2015 | 4147 | 0.090 |
Why?
| Clothing | 1 | 2009 | 6 | 0.090 |
Why?
| Meconium | 2 | 1999 | 5 | 0.090 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 80 | 0.090 |
Why?
| Exercise Tolerance | 1 | 2009 | 48 | 0.090 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.090 |
Why?
| Social Perception | 1 | 2009 | 32 | 0.090 |
Why?
| Suppositories | 3 | 2015 | 3 | 0.090 |
Why?
| Physician's Role | 1 | 2009 | 55 | 0.090 |
Why?
| Patient Preference | 1 | 2009 | 38 | 0.090 |
Why?
| Medical History Taking | 1 | 2009 | 51 | 0.090 |
Why?
| Physicians | 2 | 2012 | 247 | 0.090 |
Why?
| Anthropometry | 2 | 2006 | 96 | 0.080 |
Why?
| Research Design | 2 | 2008 | 374 | 0.080 |
Why?
| Attitude to Death | 1 | 2008 | 12 | 0.080 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 39 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 281 | 0.080 |
Why?
| Emergency Treatment | 2 | 2008 | 32 | 0.080 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 5 | 0.080 |
Why?
| Cardiotocography | 2 | 2005 | 10 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 78 | 0.080 |
Why?
| Forecasting | 2 | 2007 | 161 | 0.080 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 9 | 0.080 |
Why?
| Fecal Incontinence | 1 | 2008 | 11 | 0.080 |
Why?
| Creatinine | 2 | 2006 | 169 | 0.080 |
Why?
| Societies, Medical | 2 | 2006 | 194 | 0.080 |
Why?
| Constipation | 1 | 2008 | 33 | 0.080 |
Why?
| p-Aminohippuric Acid | 2 | 1999 | 12 | 0.080 |
Why?
| Spectrophotometry | 2 | 1999 | 36 | 0.080 |
Why?
| Brain | 1 | 2016 | 1387 | 0.080 |
Why?
| Administration, Intravenous | 2 | 2020 | 75 | 0.080 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.080 |
Why?
| Genetic Diseases, Inborn | 2 | 1999 | 26 | 0.080 |
Why?
| Breast Feeding | 1 | 2009 | 189 | 0.080 |
Why?
| Double-Blind Method | 3 | 2020 | 742 | 0.070 |
Why?
| Nurse's Role | 1 | 2007 | 90 | 0.070 |
Why?
| Abortion, Induced | 2 | 1998 | 20 | 0.070 |
Why?
| Body Size | 1 | 2007 | 30 | 0.070 |
Why?
| Sepsis | 3 | 2009 | 251 | 0.070 |
Why?
| Antacids | 1 | 2006 | 12 | 0.070 |
Why?
| Workload | 1 | 2006 | 52 | 0.070 |
Why?
| Thinness | 1 | 2006 | 57 | 0.070 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
| Drug Administration Schedule | 4 | 2011 | 401 | 0.070 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 49 | 0.070 |
Why?
| Thrombocytopenia | 4 | 2000 | 99 | 0.070 |
Why?
| Mesothelioma | 1 | 2005 | 19 | 0.070 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 8 | 0.070 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.070 |
Why?
| Uterine Neoplasms | 1 | 2005 | 63 | 0.070 |
Why?
| Leptin | 1 | 2007 | 154 | 0.070 |
Why?
| Gene Frequency | 3 | 2010 | 120 | 0.070 |
Why?
| Analgesics | 1 | 2006 | 106 | 0.070 |
Why?
| Pain, Postoperative | 1 | 2006 | 161 | 0.070 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 2 | 0.060 |
Why?
| Hypoglycemia | 1 | 2005 | 61 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2009 | 352 | 0.060 |
Why?
| Vagina | 2 | 2011 | 47 | 0.060 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 67 | 0.060 |
Why?
| Workplace | 1 | 2005 | 99 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 232 | 0.060 |
Why?
| Proteins | 1 | 2007 | 376 | 0.060 |
Why?
| False Positive Reactions | 3 | 2007 | 68 | 0.060 |
Why?
| Calcium | 1 | 2006 | 432 | 0.060 |
Why?
| Biophysics | 2 | 2004 | 20 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 11 | 0.060 |
Why?
| Thrombophlebitis | 1 | 2004 | 28 | 0.060 |
Why?
| Palliative Care | 1 | 2006 | 188 | 0.060 |
Why?
| Urogenital System | 1 | 2003 | 5 | 0.060 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 10 | 0.060 |
Why?
| Glycoproteins | 1 | 2004 | 132 | 0.060 |
Why?
| Swimming | 1 | 2003 | 30 | 0.060 |
Why?
| Infusion Pumps | 1 | 2003 | 13 | 0.060 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.060 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 58 | 0.060 |
Why?
| Recurrence | 2 | 2003 | 690 | 0.060 |
Why?
| Outpatients | 1 | 2004 | 123 | 0.060 |
Why?
| Sphingomyelins | 2 | 2000 | 8 | 0.060 |
Why?
| Propionates | 1 | 2003 | 28 | 0.060 |
Why?
| Phosphatidylcholines | 2 | 2000 | 33 | 0.060 |
Why?
| Autopsy | 1 | 2022 | 53 | 0.060 |
Why?
| Multiple Organ Failure | 1 | 2003 | 56 | 0.060 |
Why?
| Emergencies | 2 | 2021 | 92 | 0.050 |
Why?
| Hospital Costs | 1 | 2003 | 84 | 0.050 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| Blood Pressure Determination | 2 | 2003 | 51 | 0.050 |
Why?
| Aspartate Aminotransferases | 3 | 1999 | 57 | 0.050 |
Why?
| Disseminated Intravascular Coagulation | 2 | 1999 | 8 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 34 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 300 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 35 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 293 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 221 | 0.050 |
Why?
| Wound Healing | 2 | 1994 | 228 | 0.050 |
Why?
| Risk | 3 | 2013 | 343 | 0.050 |
Why?
| Proteinuria | 3 | 1999 | 52 | 0.050 |
Why?
| Administration, Oral | 2 | 2015 | 459 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 3 | 2006 | 1476 | 0.050 |
Why?
| Seizures | 1 | 2003 | 208 | 0.050 |
Why?
| Leukocytosis | 1 | 2000 | 14 | 0.050 |
Why?
| Respiration | 1 | 2000 | 99 | 0.050 |
Why?
| Shoulder | 2 | 2008 | 37 | 0.050 |
Why?
| Models, Theoretical | 2 | 1999 | 184 | 0.050 |
Why?
| Intensive Care Units | 1 | 2021 | 231 | 0.050 |
Why?
| Sodium Chloride | 2 | 1998 | 67 | 0.050 |
Why?
| Blood Gas Analysis | 2 | 2003 | 32 | 0.050 |
Why?
| Disorders of Sex Development | 1 | 1999 | 7 | 0.040 |
Why?
| Embryo Transfer | 1 | 2019 | 22 | 0.040 |
Why?
| Erythrocyte Count | 1 | 1999 | 4 | 0.040 |
Why?
| Fetal Hemoglobin | 1 | 1999 | 5 | 0.040 |
Why?
| Fetomaternal Transfusion | 1 | 1999 | 3 | 0.040 |
Why?
| Mental Health | 1 | 2022 | 245 | 0.040 |
Why?
| Placentation | 1 | 2019 | 9 | 0.040 |
Why?
| Lung Diseases | 1 | 2000 | 86 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 29 | 0.040 |
Why?
| Palpation | 1 | 1998 | 7 | 0.040 |
Why?
| Weather | 1 | 1998 | 7 | 0.040 |
Why?
| Labor Presentation | 1 | 1998 | 1 | 0.040 |
Why?
| Obstetrical Forceps | 2 | 2015 | 5 | 0.040 |
Why?
| Dilatation and Curettage | 2 | 1998 | 2 | 0.040 |
Why?
| Genotype | 2 | 2010 | 599 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 569 | 0.040 |
Why?
| Gels | 1 | 1998 | 19 | 0.040 |
Why?
| Databases, Factual | 2 | 2015 | 684 | 0.040 |
Why?
| Animals | 1 | 2014 | 14385 | 0.040 |
Why?
| Gaucher Disease | 1 | 1998 | 17 | 0.040 |
Why?
| Alanine Transaminase | 2 | 1999 | 151 | 0.040 |
Why?
| Skull | 2 | 1995 | 79 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 1998 | 109 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 225 | 0.040 |
Why?
| Carboprost | 1 | 1998 | 1 | 0.040 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 1998 | 2 | 0.040 |
Why?
| Cerebral Hemorrhage | 2 | 2014 | 102 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 139 | 0.040 |
Why?
| Georgia | 1 | 2017 | 40 | 0.040 |
Why?
| Chronic Disease | 2 | 2003 | 614 | 0.040 |
Why?
| Patient Discharge | 1 | 2000 | 353 | 0.040 |
Why?
| Critical Care | 1 | 2000 | 234 | 0.040 |
Why?
| Embryonic and Fetal Development | 1 | 1997 | 15 | 0.040 |
Why?
| Evaluation Studies as Topic | 2 | 1998 | 107 | 0.040 |
Why?
| APACHE | 1 | 2017 | 24 | 0.040 |
Why?
| Indicator Dilution Techniques | 2 | 1997 | 11 | 0.040 |
Why?
| Self Care | 1 | 1998 | 147 | 0.040 |
Why?
| Injections, Intramuscular | 2 | 2009 | 50 | 0.040 |
Why?
| Isotonic Solutions | 1 | 1996 | 21 | 0.040 |
Why?
| Nicotine | 1 | 2018 | 207 | 0.040 |
Why?
| Water-Electrolyte Imbalance | 1 | 1996 | 17 | 0.040 |
Why?
| Therapeutic Irrigation | 2 | 1993 | 27 | 0.040 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 173 | 0.040 |
Why?
| Suture Techniques | 2 | 1994 | 70 | 0.040 |
Why?
| Chlorides | 1 | 1996 | 58 | 0.040 |
Why?
| Transportation | 1 | 2016 | 31 | 0.040 |
Why?
| Psychometrics | 1 | 2017 | 241 | 0.030 |
Why?
| Dinoprost | 1 | 1995 | 12 | 0.030 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 346 | 0.030 |
Why?
| Rupture | 1 | 2015 | 31 | 0.030 |
Why?
| Flow Cytometry | 1 | 1999 | 546 | 0.030 |
Why?
| Occupations | 1 | 1995 | 17 | 0.030 |
Why?
| Florida | 1 | 1995 | 59 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 21 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 159 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 18 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| Teratoma | 1 | 1995 | 24 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 374 | 0.030 |
Why?
| Hematologic Tests | 1 | 1995 | 11 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 126 | 0.030 |
Why?
| Liver Function Tests | 1 | 1995 | 43 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 316 | 0.030 |
Why?
| Cervical Length Measurement | 1 | 2014 | 1 | 0.030 |
Why?
| Discriminant Analysis | 1 | 1994 | 34 | 0.030 |
Why?
| Interleukin-8 | 1 | 1994 | 97 | 0.030 |
Why?
| Glucocorticoids | 1 | 2016 | 234 | 0.030 |
Why?
| Radiography | 1 | 2015 | 524 | 0.030 |
Why?
| Enterocolitis, Necrotizing | 1 | 2014 | 36 | 0.030 |
Why?
| Stress, Physiological | 1 | 1995 | 194 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 1999 | 562 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 13 | 0.030 |
Why?
| Povidone-Iodine | 1 | 1993 | 5 | 0.030 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2014 | 69 | 0.030 |
Why?
| Biometry | 3 | 2000 | 28 | 0.030 |
Why?
| Interleukin-6 | 1 | 1994 | 315 | 0.030 |
Why?
| Maternal Welfare | 2 | 2004 | 10 | 0.030 |
Why?
| Leukocyte Count | 2 | 2004 | 77 | 0.030 |
Why?
| New Zealand | 1 | 2012 | 18 | 0.030 |
Why?
| Ascites | 1 | 1992 | 28 | 0.030 |
Why?
| Auscultation | 1 | 2012 | 10 | 0.030 |
Why?
| Self Report | 1 | 2013 | 204 | 0.030 |
Why?
| Health Care Surveys | 1 | 2012 | 195 | 0.030 |
Why?
| Canada | 1 | 2012 | 104 | 0.030 |
Why?
| Disease Progression | 1 | 1995 | 913 | 0.030 |
Why?
| Patient Safety | 1 | 2012 | 121 | 0.030 |
Why?
| Oximetry | 1 | 2012 | 62 | 0.030 |
Why?
| Brain Neoplasms | 1 | 1995 | 284 | 0.030 |
Why?
| Area Under Curve | 1 | 2011 | 205 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 5 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 259 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 823 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 13 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 314 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 27 | 0.020 |
Why?
| Uric Acid | 2 | 1999 | 32 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 55 | 0.020 |
Why?
| Nausea | 2 | 1999 | 52 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 55 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 177 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 41 | 0.020 |
Why?
| Vomiting | 2 | 1999 | 73 | 0.020 |
Why?
| Western Australia | 1 | 2008 | 6 | 0.020 |
Why?
| Virginia | 1 | 2008 | 14 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 116 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 4 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 138 | 0.020 |
Why?
| Rectum | 1 | 2008 | 51 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 47 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 47 | 0.020 |
Why?
| Fathers | 1 | 2007 | 17 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 10 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 43 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 146 | 0.020 |
Why?
| Femur | 2 | 2000 | 144 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 244 | 0.020 |
Why?
| Liver | 2 | 2009 | 1225 | 0.020 |
Why?
| Heart Failure | 1 | 1992 | 541 | 0.020 |
Why?
| Registries | 1 | 2008 | 553 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 44 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 13 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 23 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 19 | 0.020 |
Why?
| Washington | 1 | 2005 | 46 | 0.020 |
Why?
| Diastole | 1 | 2005 | 79 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 114 | 0.020 |
Why?
| Cecostomy | 1 | 2004 | 1 | 0.020 |
Why?
| Pain Measurement | 1 | 2006 | 246 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 214 | 0.020 |
Why?
| Comorbidity | 1 | 2007 | 663 | 0.020 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.020 |
Why?
| Phenotype | 1 | 2007 | 820 | 0.020 |
Why?
| Wound Infection | 1 | 2004 | 31 | 0.020 |
Why?
| Suicide | 1 | 2005 | 77 | 0.010 |
Why?
| Overweight | 1 | 2006 | 240 | 0.010 |
Why?
| Decision Making | 1 | 2006 | 290 | 0.010 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 36 | 0.010 |
Why?
| Injury Severity Score | 1 | 2004 | 178 | 0.010 |
Why?
| Fetal Hypoxia | 1 | 2003 | 2 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 3 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 83 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 88 | 0.010 |
Why?
| Heparin | 1 | 2004 | 97 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 154 | 0.010 |
Why?
| Injections, Intravenous | 1 | 2003 | 148 | 0.010 |
Why?
| Fever | 1 | 2004 | 129 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 53 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 139 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 237 | 0.010 |
Why?
| Heart Rate | 1 | 2003 | 357 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 501 | 0.010 |
Why?
| Karyotyping | 1 | 1999 | 92 | 0.010 |
Why?
| Asthma | 1 | 2003 | 293 | 0.010 |
Why?
| Headache | 1 | 1999 | 78 | 0.010 |
Why?
| Liver Diseases | 1 | 1999 | 87 | 0.010 |
Why?
| Pulse | 1 | 1998 | 21 | 0.010 |
Why?
| Stomach | 1 | 1999 | 80 | 0.010 |
Why?
| Injections | 1 | 1998 | 61 | 0.010 |
Why?
| Mathematics | 1 | 1998 | 47 | 0.010 |
Why?
| Aminohippuric Acids | 1 | 1997 | 1 | 0.010 |
Why?
| Blood | 1 | 1997 | 30 | 0.010 |
Why?
| Heart Arrest | 1 | 1999 | 159 | 0.010 |
Why?
| Acidosis, Respiratory | 1 | 1997 | 2 | 0.010 |
Why?
| Blood Specimen Collection | 1 | 1997 | 39 | 0.010 |
Why?
| Twin Studies as Topic | 1 | 1996 | 3 | 0.010 |
Why?
| Pain | 1 | 1999 | 405 | 0.010 |
Why?
| Inflammation | 1 | 2000 | 674 | 0.010 |
Why?
| Feasibility Studies | 1 | 1997 | 398 | 0.010 |
Why?
| Diagnostic Tests, Routine | 1 | 1995 | 31 | 0.010 |
Why?
| Extraction, Obstetrical | 1 | 1992 | 3 | 0.010 |
Why?
| Nerve Compression Syndromes | 1 | 1992 | 8 | 0.010 |
Why?
| Granulation Tissue | 1 | 1992 | 12 | 0.010 |
Why?
| Anemia, Hemolytic | 1 | 1992 | 12 | 0.010 |
Why?
| Debridement | 1 | 1992 | 54 | 0.010 |
Why?
| Random Allocation | 1 | 1992 | 312 | 0.010 |
Why?
| Syndrome | 1 | 1992 | 252 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 1994 | 309 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|